Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

A cellular housekeeping process where cells break down and recycle damaged components. Declines with age and is stimulated by fasting.

What is Intermittent fasting?

An eating pattern that cycles between periods of fasting and eating. Various protocols (16:8, 5:2) are studied for metabolic, cardiovascular, and longevity benefits.

What is Zone 2 cardio?

Low-intensity aerobic exercise performed at roughly 60–70% of maximum heart rate, primarily using the aerobic energy system. Associated with mitochondrial health and longevity.

Geographic regions identified by researchers where people consistently live longer and healthier lives than average, including Sardinia, Okinawa, and Loma Linda.

Join the 2027 MDA Conference on Neuromuscular Advances

Researchers have announced that registration is now open for the 2027 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, set to take place from March 21 to 24, 2027, in Orlando, Florida. This conference is a key international event focused on neuromuscular diseases, bringing together leading experts in research, healthcare, and advocacy. The program will feature a variety of sessions and presentations that highlight cutting-edge advancements in clinical trials, gene therapies, and AI-driven drug discovery, all aimed at improving the understanding and treatment of neuromuscular conditions.

For those interested in healthy aging and longevity, this conference is particularly significant. It showcases the latest research on diseases like muscular dystrophy and amyotrophic lateral sclerosis (ALS), which affect muscle strength and function. Attendees will gain insights into how emerging therapies and technologies could potentially enhance muscle health and overall well-being for individuals living with these conditions. With over 2,400 attendees expected, including healthcare professionals and advocates, the event serves as a platform for collaboration and knowledge-sharing that may lead to new treatment options.

The MDA conference is an important gathering that reflects the rapid advancements in neuromuscular research. While the conference will feature a mix of established findings and emerging ideas, it is essential to note that many of the presented studies and therapies are still in early stages of development. The event aims to translate scientific discoveries into real-world applications, but attendees should remain aware that not all advancements will be immediately available for clinical use.

If you’re interested in attending, early bird registration is available until December 31, 2026, and families affected by neuromuscular diseases can participate at a reduced rate or for free. This is a unique opportunity to engage with experts and learn more about the future of treatments that could improve health outcomes.

For more information, visit the MDA Clinical & Scientific Conference announcement.